Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics
N Wang - Journal of Cancer Research and Clinical Oncology, 2023 - Springer
Background Acute myeloid leukemia (AML) is a hematological cancer driven on by aberrant
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …
Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics.
N Wang - Journal of Cancer Research & Clinical Oncology, 2023 - search.ebscohost.com
Background: Acute myeloid leukemia (AML) is a hematological cancer driven on by aberrant
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …
Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics.
N Wang - Journal of Cancer Research and Clinical Oncology, 2023 - europepmc.org
Background Acute myeloid leukemia (AML) is a hematological cancer driven on by aberrant
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …
Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics
N Wang - Journal of cancer research and clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Acute myeloid leukemia (AML) is a hematological cancer driven on by aberrant
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …
myeloid precursor cell proliferation and differentiation. A prognostic model was created in …